<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Almanac of Clinical Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Almanac of Clinical Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Альманах клинической медицины</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-0505</issn><issn publication-format="electronic">2587-9294</issn><publisher><publisher-name xml:lang="en">Moscow Regional Research and Clinical Institute (MONIKI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66</article-id><article-id pub-id-type="doi">10.18786/2072-0505-2015-1-42-45</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>THE PROBLEM OF OBESITY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ПРОБЛЕМЫ ОЖИРЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE ROLE OF NUTRIGENOMICS IN CORRECTION OF METABOLIC ABNORMALITIES</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ НУТРИГЕНОМИКИ В КОРРЕКЦИИ МЕТАБОЛИЧЕСКИХ НАРУШЕНИЙ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Misnikova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Мисникова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Misnikova Inna Vladimirovna – MD, PhD, Leading Research Fellow, Department of Therapeutic Endocrinology; Professor, Chair of Endocrinology, Postgraduate Training Faculty</p><p>* 61/2–9 Shchepkina ul., Moscow, 129110, Russian Federation. Tel.: +7 (495) 688 95 93. E-mail: inna-misnikova@mail.ru</p></bio><bio xml:lang="ru"><p>Мисникова Инна Владимировна – доктор медицинских наук, вед. научный сотрудник отделения терапевтической эндокринологии, профессор кафедры эндокринологии факультета усовершенствования врачей</p><p>* 129110, г. Москва, ул. Щепкина, 61/2–9, Российская Федерация. Тел.: +7 (495) 688 95 93. E-mail: inna-misnikova@mail.ru</p></bio><email>inna-misnikova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Moscow Regional Research and Clinical Institute (MONIKI)</institution></aff><aff><institution xml:lang="ru">Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-12-20" publication-format="electronic"><day>20</day><month>12</month><year>2015</year></pub-date><volume>1</volume><issue>1</issue><issue-title xml:lang="en">Supplement 1</issue-title><issue-title xml:lang="ru">Спецвыпуск 1</issue-title><fpage>42</fpage><lpage>45</lpage><history><date date-type="received" iso-8601-date="2016-02-12"><day>12</day><month>02</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-02-12"><day>12</day><month>02</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Misnikova I.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Мисникова И.В.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Misnikova I.V.</copyright-holder><copyright-holder xml:lang="ru">Мисникова И.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://almclinmed.ru/jour/article/view/66">https://almclinmed.ru/jour/article/view/66</self-uri><abstract xml:lang="en"><p>In some patients, diet and increased physical exercise are not effective enough to prevent the development of type 2 diabetes mellitus. At present, a  new approach is proposed to elaborate the diet with consideration of specific need of an individual. Food components can cause changes in metabolism through their influence on activity of certain genes that subsequently influence human proteome and metabolome. It is assumed that nutrients may influence methylation of deoxyribonucleic acid. A number of studies established an interaction between some foods and genes associated with obesity and type 2 diabetes mellitus. Diet recommendations based on presence of certain gene polymorphisms have been developed. The spectrum of gene polymorphisms that is necessary to assess in individuals with metabolic abnormalities or with high risk of their development has been also defined.</p></abstract><trans-abstract xml:lang="ru"><p>У некоторых пациентов диета и  расширение физической активности оказываются недостаточно эффективными мерами в  отношении предотвращения развития сахарного диабета 2-го типа. Сегодня предлагается новый подход к построению диеты с учетом индивидуальных особенностей человека. Компоненты пищи могут вызывать изменения в  метаболизме через воздействие на активность определенных генов, которые, в свою очередь, влияют на протеом и  метаболом человека. Предполагается, что нутриенты могут влиять на процессы метилирования дезоксирибонуклеиновой кислоты. В  ряде исследований установлено взаимодействие между генами, ассоциированными с ожирением и сахарным диабетом 2-го типа, и некоторыми пищевыми продуктами. Разработаны рекомендации по питанию исходя из наличия тех или иных полиморфизмов генов и определен тот спектр полиморфизмов генов, который необходимо исследовать у  лиц с  метаболическими нарушениями или с  высоким риском их развития. </p></trans-abstract><kwd-group xml:lang="en"><kwd>nutrigenomics, proteomics, metabolomics, leptin, obesity, type 2 diabetes mellitus, diet.</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нутригеномика, протеомика, метаболомика, лептин, ожирение, сахарный диабет 2-го типа, диета</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Ross SA. Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci. 2003;983:197–207.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Milner J, Trujillo EB, Kaefer CM, Ross S. Nutrigenomics. In: Biosocial Surveys. Committee on Advances in Collecting and Utilizing Biological Indicators and Genetic Information in Social Science Surveys. Weinstein M, Vaupel JW, Wachter KW, editors; Committee on Population, Division of Behavioral and Social Sciences and Education. National Research Council. Washington: The National Academies Press; 2008.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Zhao T, Zhao J, Yang W. Association of the fatty acid-binding protein 2 gene Ala54Thr polymorphism with insulin resistance and blood glucose: a meta-analysis in 13451 subjects. Diabetes Metab Res Rev. 2010;26(5):357–64.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. de Luis D, Aller R, Izaola O, Sagrado MG, de la Fuente B, Conde R, Primo D. Effect of fatty acid-binding protein 2 Ala54Thr genotype on weight loss and cardiovascular risk factors after a high-polyunsaturated fat diet in obese patients. J Investig Med. 2012;60(8):1194–8.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R. Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients. J Endocrinol Invest. 2013;36(6):402–6.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell. 1999;3(3):397–403.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest. 1996;97(11):2553–61.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Tönjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care. 2006;29(11):2489–97.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.Alsaleh A, O'Dell SD, Frost GS, Griffin BA, Lovegrove JA, Jebb SA, Sanders TA; RISCK Study investigators. Interaction of PPARG Pro12Ala with dietary fat influences plasma lipids in subjects at cardiometabolic risk. J Lipid Res. 2011;52(12):2298–303.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Baratta M. Leptin – from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit. 2002;8(12):RA282–92.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.Панков ЮА. Мутации в ключевых генах, контролирующих развитие ожирения и сахарного диабета. Молекулярная биология. 2013;47(1):38–49. (Pankov YuA. [Mutations of key genes controlling for development of obesity and diabetes mellitus]. Molekulyarnaya biologiya. 2013;47(1):38–49. Russian).</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Mizuta E, Kokubo Y, Yamanaka I, Miyamoto Y, Okayama A, Yoshimasa Y, Tomoike H, Morisaki H, Morisaki T. Leptin gene and leptin receptor gene polymorphisms are associated with sweet preference and obesity. Hypertens Res. 2008;31(6):1069–77.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Murugesan D, Arunachalam T, Ramamurthy V, Subramanian S. Association of polymorphisms in leptin receptor gene with obesity and type 2 diabetes in the local population of Coimbatore. Indian J Hum Genet. 2010;16(2):72–7.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab. 2001;86(9):4434–9.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Phillips CM, Goumidi L, Bertrais S, Field MR, Ordovas JM, Cupples LA, Defoort C, Lovegrove JA, Drevon CA, Blaak EE, Gibney MJ, Kiec-Wilk B, Karlstrom B, Lopez-Miranda J, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr. 2010;140(2):238–44.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Carpenter CL, Wong AM, Li Z, Noble EP, Heber D. Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. Obesity (Silver Spring). 2013;21(9):E467–73.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Steemburgo T, Azevedo MJ, Gross JL, Milagro FI, Campión J, Martínez JA. The rs9939609 polymorphism in the FTO gene is associated with fat and fiber intakes in patients with type 2 diabetes. J Nutrigenet Nutrigenomics. 2013;6(2):97–106.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.Ortega-Azorín C, Sorlí JV, Asensio EM, Coltell O, Martínez-González MÁ, Salas-Salvadó J, Covas MI, Arós F, Lapetra J, Serra-Majem L, Gómez-Gracia E, Fiol M, Sáez-Tormo G, Pintó X, Muñoz MA, Ros E, Ordovás JM, Estruch R, Corella D. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol. 2012;11:137.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Barth SW, Koch TC, Watzl B, Dietrich H, Will F, Bub A. Moderate effects of apple juice consumption on obesity-related markers in obese men: impact of diet-gene interaction on body fat content. Eur J Nutr. 2012;51(7):841–50.</mixed-citation></ref></ref-list></back></article>
